Dogwood Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Dogwood Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.92K	Buy	+16	New	+$3.47K	﹤0.01%	552

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Dogwood Wealth Management's AXSM Position: Q2 2026 in Review

Dogwood Wealth Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 16 shares worth $3.92K. The stake represents ﹤0.01% of the portfolio and ranks #552 among its holdings.

33 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Dogwood Wealth Management held 16 shares of Axsome Therapeutics worth $3.92K as of Q2 2026.
Axsome Therapeutics was a new Dogwood Wealth Management position in Q2 2026.
Axsome Therapeutics made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #552 holding.
33 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.